A Phase 4, Multisite, Randomized, Double-Masked, Well-Controlled Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections: The QUELL Study
Research Goals
To evaluate the non-inferiority of IHEEZO (chloroprocaine ophthalmic gel 3%) compared to routine anesthesia (topical proparacaine ophthalmic solution 0.5% combined with subconjunctival lidocaine 2%) for achieving successful ocular surface anesthesia immediately before and after intravitreal injection procedures
